24 research outputs found
Programa experimental de cant en cursa
Treball acadĂšmic per a l'assignatura: EducaciĂł FĂsica i la seva didĂ ctica I. Curs: 2013-14.Resultats de la recerca sobre activitats associades a la cursa econĂČmica per al desenvolupament de la resistĂšncia aerĂČbica a les edats escolars
La reparaciĂłn econĂłmica a la vĂctima en el sistema de justicia
En este libro se recogen las investigaciones llevadas a cabo en el marco de los Trabajos Fin de Grado de la Universidad Carlos III de Madrid en los dobles grados de Derecho y AdministraciĂłn de Empresas, Derecho y EconomĂa durante los cursos 2015/16 y 2016/17.
El objetivo principal es evaluar la eficacia de la reparaciĂłn econĂłmica a la vĂctima. Para ello, se realizĂł un estudio de campo de las ejecutorias en los Juzgados de lo Penal y la Audiencia Provincial de Madrid en dos etapas, octubre de 2015 y octubre de 2016, , excluyendo delitos menores y delitos relacionados con delitos de trĂĄnsito y violencia de gĂ©nero, asĂ como aquellos donde no hubiera vĂctima.Este trabajo ha sido subvencionado en parte por los proyectos DER2015-66435-P y MTM2014-56535-R, Ministerio de EconomĂa y Competitividad, y se enmarca en el Proyecto innovaciĂłn docente de la Universidad Carlos III de Madrid titulado Eficacia y Eficiencia de la Justicia, curso 2016/2017.PrĂłlogo / Daniel Peña (pp. 19-20). -- La ineficacia del sistema
español en la compensación a través del proceso / Helena Soleto y
Aurea GranĂ© (pp. 23-97). -- Asistencia jurĂdica y turno de oficio
para la vĂctima / Alicia Calvo BarcelĂł (pp. 101-138). --
Competencia judicial en ejecuciĂłn penal / Alberto RodrĂguez Abad
(pp. 141-175). -- El fiscal en la ejecuciĂłn / MarĂa GarcĂa Navarro
(pp. 177-214). -- La participaciĂłn de la vĂctima en la ejecuciĂłn /
Sara GonzĂĄlez PĂ©rez (pp. 215-247). -- InvestigaciĂłn patrimonial del
condenado / Radad Sennouni El Harti (pp. 249-277). -- La suspensiĂłn
de la pena privativa y libertad condicional / Sara Jiménez Olbea
(pp. 281-306). -- La insolvencia del condenado / Catalina GuzmĂĄn
GuzmĂĄn (pp. 307-324). -- Eficacia del pago y percepciĂłn de
impunidad: consecuencias de la reparaciĂłn en el condenado / Rosa
GonzĂĄlez Espejo (pp. 325-342). -- Delitos contra la libertad sexual
/ MarĂa BelĂ©n Combarros GĂłmez (pp. 345-386). -- La vĂctima del
delito de trata de seres humanos e inmigraciĂłn ilegal / Eduardo
Sagra GonzĂĄlez (pp. 387-407). -- La reparaciĂłn en violencia de
gĂ©nero / Marina GarcĂa-Navas GĂłmez (pp. 409-439). -- ReparaciĂłn en
delitos contra la AdministraciĂłn PĂșblica / Irea RiobĂł Mayo (pp.
441-459). -- La reparaciĂłn econĂłmica en el caso Madrid Arena /
LucĂa Gimeno Malumbres (pp. 461-487). -- La reparaciĂłn en el proceso de menores / Miriam LĂłpez-Terradas Paniagua (pp. 489-513). -- La atenuante por reparaciĂłn del daño / Adriana Noel Afonso Carracedo (pp. 517-540). -- ReparaciĂłn y modelos de justicia reparativa / Victoria MartĂnez MartĂnez (pp. 541-567). -- Elementos bĂĄsicos de justicia restaurativa / Mireia Galindo Perpiñån (pp. 569-614). -- El acuerdo de reparaciĂłn en la justicia reparativa / Ainhoa Berrocal Cañadas (pp. 615-634). -- La indemnizaciĂłn a las vĂctimas en el Derecho comparado / Alba Peña DĂaz (pp. 637-650). -- Las indemnizaciones de la Ley 35/1995 / Inmaculada RamĂrez RodrĂguez (pp. 651-702). -- El pago de indemnizaciones por el Estado en terrorismo / Ana PĂ©rez CampĂłn (pp. 703-734)
Jardins per a la salut
Facultat de FarmĂ cia, Universitat de Barcelona. Ensenyament: Grau de FarmĂ cia. Assignatura: BotĂ nica farmacĂšutica. Curs: 2014-2015. Coordinadors: Joan Simon, CĂšsar BlanchĂ© i Maria Bosch.Els materials que aquĂ es presenten sĂłn el recull de les fitxes botĂ niques de 128 espĂšcies presents en el JardĂ Ferran Soldevila de lâEdifici HistĂČric de la UB. Els treballs han estat realitzats manera individual per part dels estudiants dels grups M-3 i T-1 de lâassignatura BotĂ nica FarmacĂšutica durant els mesos de febrer a maig del curs 2014-15 com a resultat final del Projecte dâInnovaciĂł Docent «Jardins per a la salut: aprenentatge servei a BotĂ nica farmacĂšutica» (codi 2014PID-UB/054). Tots els treballs sâhan dut a terme a travĂ©s de la plataforma de GoogleDocs i han estat tutoritzats pels professors de lâassignatura. Lâobjectiu principal de lâactivitat ha estat fomentar lâaprenentatge autĂČnom i col·laboratiu en BotĂ nica farmacĂšutica. TambĂ© sâha pretĂšs motivar els estudiants a travĂ©s del retorn de part del seu esforç a la societat a travĂ©s dâuna experiĂšncia dâAprenentatge-Servei, deixant disponible finalment el treball dels estudiants per a poder ser consultable a travĂ©s dâuna Web pĂșblica amb la possibilitat de poder-ho fer in-situ en el propi jardĂ mitjançant codis QR amb un smartphone
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections
IMPORTANCE The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these infections is critical, for which some neglected drugs may be an option. OBJECTIVE To determine whether fosfomycin is noninferior to ceftriaxone or meropenem in the targeted treatment of bacteremic urinary tract infections (bUTIs) due to MDR E coli. DESIGN, SETTING, AND PARTICIPANTS This multicenter, randomized, pragmatic, open clinical trial was conducted at 22 Spanish hospitals from June 2014 to December 2018. Eligible participants were adult patients with bacteremic urinary tract infections due to MDR E coli; 161 of 1578 screened patients were randomized and followed up for 60 days. Data were analyzed in May 2021. INTERVENTIONS Patients were randomized 1 to 1 to receive intravenous fosfomycin disodium at 4 g every 6 hours (70 participants) or a comparator (ceftriaxone or meropenem if resistant; 73 participants) with the option to switch to oral fosfomycin trometamol for the fosfomycin group or an active oral drug or pa renteral ertapenem for the comparator group after 4 days. MAIN OUTCOMES AND MEASURES The primary outcome was clinical and microbiological cure (CMC) 5 to 7 days after finalization of treatment; a noninferiority margin of 7% was considered. RESULTS Among 143 patients in the modified intention-to-treat population (median [IQR] age, 72 [62-81] years; 73 [51.0%] women), 48 of 70 patients (68.6%) treated with fosfomycin and 57 of 73 patients (78.1%) treated with comparators reached CMC (risk difference, -9.4 percentage points; 1-sided 95% CI, -21.5 to infinity percentage points; P = .10). While clinical or microbiological failure occurred among 10 patients (14.3%) treated with fosfomycin and 14 patients (19.7%) treated with comparators (risk difference, -5.4 percentage points; 1-sided 95% CI. -infinity to 4.9; percentage points; P = .19), an increased rate of adverse event-related discontinuations occurred with fosfomycin vs comparators (6 discontinuations [8.5%] vs 0 discontinuations; P = .006). In an exploratory analysis among a subset of 38 patients who underwent rectal colonization studies, patients treated with fosfomycin acquired a new ceftriaxone-resistant or meropenem-resistant gram-negative bacteria at a decreased rate compared with patients treated with comparators (0 of 21 patients vs 4 of 17 patients [23.5%]; 1-sided P = .01). CONCLUSIONS AND RELEVANCE This study found that fosfomycin did not demonstrate noninferiority to comparators as targeted treatment of bUTI from MDR E coli; this was due to an increased rate of adverse event-related discontinuations. This finding suggests that fosfomycin may be considered for selected patients with these infections
CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
ObjectivesCARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain.MethodsIn total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis.ResultsIn total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXAâ48 (263/377), blaKPCâ3 (62/377), blaVIMâ1 (28/377), and blaNDMâ1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5).ConclusionThis study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
Abstract
Background
Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres.
Methods
This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and lowâmiddle-income countries.
Results
In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of âsingle-useâ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for lowâmiddle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia.
Conclusion
This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both highâ and lowâmiddleâincome countries
Programa experimental de cant en cursa
Treball acadĂšmic per a l'assignatura: EducaciĂł FĂsica i la seva didĂ ctica I. Curs: 2013-14.Resultats de la recerca sobre activitats associades a la cursa econĂČmica per al desenvolupament de la resistĂšncia aerĂČbica a les edats escolars
FilosofĂa y Humor: el cine como recurso audiovisual para pensar desde la risa filosĂłfica
Depto. de LĂłgica y FilosofĂa TeĂłricaFac. de FilosofĂaFALSEsubmitte